Dong-A Socio Holdings Co., Ltd. (KRX:000640)
97,800
+400 (0.41%)
Feb 21, 2025, 9:00 AM KST
Dong-A Socio Holdings Revenue
Dong-A Socio Holdings had revenue of 356.89B KRW in the quarter ending September 30, 2024, with 23.40% growth. This brings the company's revenue in the last twelve months to 1.29T, up 18.14% year-over-year. In the year 2023, Dong-A Socio Holdings had annual revenue of 1.13T with 11.54% growth.
Revenue (ttm)
1,288.65B
Revenue Growth
+18.14%
P/S Ratio
0.47
Revenue / Employee
233.03M
Employees
5,530
Market Cap
611.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,132.00B | 117.14B | 11.54% |
Dec 31, 2022 | 1,014.86B | 132.92B | 15.07% |
Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
Dec 31, 2020 | 783.32B | 13.63B | 1.77% |
Dec 31, 2019 | 769.69B | 62.19B | 8.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanall Biopharma | 134.24B |
Hanmi Science | 1,283.65B |